title: Determination of diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone in plasma by solid-phase extraction and high-performance liquid chromatography.
authors.affiliation: Bath Cancer Research Unit, Royal United Hospital, U.K.
authors.forename: R F
authors.initials: RF
authors.lastname: Betteridge
authors.forename: A G
authors.initials: AG
authors.lastname: Bosanquet
authors.forename: P
authors.initials: P
authors.lastname: Hunt
authors.forename: E D
authors.initials: ED
authors.lastname: Gilby
mesh_terms: D000970:Antineoplastic Agents / Q000097:blood* / Q000493:pharmacokinetics; D001388:Aziridines / Q000097:blood* / Q000493:pharmacokinetics; D001389:Azirines / Q000097:blood*; D016227:Benzoquinones; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D006801:Humans; D011485:Protein Binding; D013056:Spectrophotometry, Ultraviolet; D014461:Ultracentrifugation
chemical_list: D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D016227:Benzoquinones; C029108:diaziquone